Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 147
Filtrar
1.
In. Faculty of Medical Sciences, The University of the West Indies. 23rd Annual Student Research Day. Port of Sapin, Faculty of Medical Sciences,The University of the West Indies, October 14, 2021. .
No convencional en Inglés | MedCarib | ID: biblio-1337766

RESUMEN

Telemedicine is an unexplored practice that has received advocacy due to technological advancement and social distancing regulations imposed due to Covid-19. According to the W.H.O1 50% of its member states have implemented a national telemedicine policy, stimulating the question "Why hasn't Trinidad and Tobago introduced a structured and stable telemedical service?" To investigate this, we target experienced physicians to understand the benefits and limitations of adapting telemedical technology into the current medical model. Utilization of Telemedicine in developing countries, like Trinidad and Tobago, is very promising as it can improve healthcare accessibility and elevate the quality of care for potential patients in rural areas


Asunto(s)
Humanos , Trinidad y Tobago , COVID-19 , Telemedicina
2.
In. The University of the West Indies, Faculty of Medical Sciences. Faculty of Medical Sciences, Research Day. St. Augustine, Caribbean Medical Journal, March 21, 2019. .
No convencional en Inglés | MedCarib | ID: biblio-1025491

RESUMEN

Objective: To perform in-vitro quality control testing of different brands of 400 mg Ibuprofen conventional tablet as per the pharmacopoeia standard and compare them to those are available in hospitals and pharmacies in Trinidad. Design and Methodology: The four popular brands (A, B, C, D) of Ibuprofen conventional tablet of 400 mg strength were chosen. The Ibuprofen tablets were obtained from government hospital pharmacies as well as from local private pharmacies. The in-vitro evaluation tests-friability, weight variation, disintegration time, dissolution and drug assay tests were performed as per the United States Pharmacopoeia. Results: The results showed that all the tablets passed the uniformity of weight (<± 5%), friability (<1%), disintegrated in less than 30 minutes (Ibuprofen coated tablets) and drug assays showed that the amount of drugs varied between 90-100%. The Invitro dissolution study in phosphate buffer pH 7.2 showed that about 95% drug release in 30 minutes. Conclusion: The results of all these parameters of different brands Ibuprofen of tablets were in the pharmacopoeia limits so it could be concluded that marketed pharmaceutical tablets of Ibuprofen of these brands satisfy quality control limits of pharmacopoeia.


Asunto(s)
Humanos , Masculino , Femenino , Control de Calidad , Ibuprofeno , Trinidad y Tobago , Región del Caribe/etnología
3.
Sci Rep ; 8(1): 5450, 2018 04 03.
Artículo en Inglés | MEDLINE | ID: mdl-29615668

RESUMEN

Tissue specific biosynthesis of secondary metabolites is a distinguished feature of medicinal plants. Withania somnifera, source of pharmaceutically important withanolides biosynthesizes withaferin-A in leaves and withanolide-A in roots. To increase the in planta withanolides production, a sustainable approach needs to be explored. Here, we isolated endophytes from different parts of W. somnifera plants and their promising role in in planta withanolide biosynthesis was established in both in-vivo grown as well in in-vitro raised composite W. somnifera plants. Overall, the fungal endophytes improved photosynthesis, plant growth and biomass, and the root-associated bacterial endophytes enhanced the withanolide content in both in-vivo and in-vitro grown plants by modulating the expression of withanolide biosynthesis genes in leaves and roots. Surprisingly, a few indole-3-acetic acid (IAA)-producing and nitrogen-fixing root-associated endophytes could induce the biosynthesis of withaferin-A in roots by inducing in planta IAA-production and upregulating the expression of withanolide biosynthesis genes especially MEP-pathway genes (DXS and DXR) in roots as well. Results indicate the role of endophytes in modulating the synthesis and site of withanolides production and the selected endophytes can be used for enhancing the in planta withanolide production and enriching roots with pharmaceutically important withaferin-A which is generally absent in roots.


Asunto(s)
Endófitos/fisiología , Withania/metabolismo , Withania/microbiología , Witanólidos/metabolismo , Biomasa , Fotosíntesis , Pigmentos Biológicos/metabolismo , Hojas de la Planta/metabolismo , Raíces de Plantas/metabolismo , Simbiosis , Withania/genética
4.
Sci Rep ; 7: 41867, 2017 02 03.
Artículo en Inglés | MEDLINE | ID: mdl-28157221

RESUMEN

Plant-associated beneficial microbes have been explored to fulfill the imperative function for plant health. However, their impact on the host secondary metabolite production and nematode disease management remains elusive. Our present work has shown that chitinolytic microbes viz., Chitiniphilus sp. MTN22 and Streptomyces sp. MTN14 singly as well as in combination modulated the biosynthetic pathway of bacoside A and systemic defense mechanism against Meloidogyne incognita in Bacopa monnieri. Interestingly, expression of bacoside biosynthetic pathway genes (3-Hydroxy-3-methylglutaryl coenzyme A reductase, mevalonate diphosphate decarboxylase, and squalene synthase) were upregulated in plants treated with the microbial combination in the presence as well as in absence of M. incognita stress. These microbes not only augmented bacoside A production (1.5 fold) but also strengthened host resistance via enhancement in chlorophyll a, defense enzymes and phenolic compounds like gallic acid, syringic acid, ferulic acid and cinnamic acid. Furthermore, elevated lignification and callose deposition in the microbial combination treated plants corroborate well with the above findings. Overall, the results provide novel insights into the underlying mechanisms of priming by beneficial microbes and underscore their capacity to trigger bacoside A production in B. monnieri under biotic stress.


Asunto(s)
Bacopa/microbiología , Inmunidad de la Planta , Saponinas/biosíntesis , Tylenchoidea/patogenicidad , Animales , Bacopa/inmunología , Bacopa/metabolismo , Carboxiliasas/genética , Carboxiliasas/metabolismo , Farnesil Difosfato Farnesil Transferasa/genética , Farnesil Difosfato Farnesil Transferasa/metabolismo , Regulación de la Expresión Génica de las Plantas , Interacciones Huésped-Patógeno , Hidroximetilglutaril-CoA-Reductasas NADP-Dependientes/genética , Hidroximetilglutaril-CoA-Reductasas NADP-Dependientes/metabolismo , Proteínas de Plantas/genética , Proteínas de Plantas/metabolismo , Streptomyces/patogenicidad , Estrés Fisiológico , Triterpenos , Regulación hacia Arriba
5.
World J Microbiol Biotechnol ; 32(10): 167, 2016 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-27565777

RESUMEN

Artemisia annua L. is mostly known for a bioactive metabolite, artemisinin, an effective sesquiterpene lactone used against malaria without any reputed cases of resistance. In this experiment, bioinoculants viz., Streptomyces sp. MTN14, Bacillus megaterium MTN2RP and Trichoderma harzianum Thu were applied as growth promoting substances to exploit full genetic potential of crops in terms of growth, yield, nutrient uptake and particularly artemisinin content. Further, multi-use of the bioinoculants singly and in combinations for the enhancement of antioxidant potential and therapeutic value was also undertaken which to our knowledge has never been investigated in context with microbial application. The results demonstrated that a significant (P < 0.05) increase in growth, nutrient uptake, total phenolic, flavonoid, free radical scavenging activity, ferric reducing antioxidant power, reducing power and total antioxidant capacity were observed in the A. annua treated with a combination of bioinoculants in comparison to control. Most importantly, an increase in artemisinin content and yield by 34 and 72 % respectively in the treatment having all the three microbes was observed. These results were further authenticated by the PCA analysis which showed positive correlation between plant macronutrients and antioxidant content with plant growth and artemisinin yield of A. annua. The present study thus highlights a possible new application of compatible bioinoculants for enhancing the growth along with antioxidant and therapeutic value of A. annua.


Asunto(s)
Antioxidantes/metabolismo , Artemisia annua/crecimiento & desarrollo , Artemisia annua/microbiología , Artemisininas/metabolismo , Artemisia annua/metabolismo , Bacillus megaterium/fisiología , Biomasa , Productos Agrícolas , Flavonoides/metabolismo , Regulación de la Expresión Génica de las Plantas , Fenoles/metabolismo , Streptomyces/fisiología , Trichoderma/fisiología
6.
Physiol Mol Biol Plants ; 22(2): 253-60, 2016 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-27436916

RESUMEN

In the present investigation, metabolites of Streptomyces sp. MTN14 and Trichoderma harzianum ThU significantly enhanced biomass yield (3.58 and 3.48 fold respectively) in comparison to the control plants. The secondary metabolites treatments also showed significant augmentation (0.75-2.25 fold) in withanolide A, a plant secondary metabolite. Lignin deposition, total phenolic and flavonoid content in W. somnifera were maximally induced in treatment having T. harzianum metabolites. Also, Trichoderma and Streptomyces metabolites were found much better in invoking in planta contents and antioxidants compared with their live culture treatments. Therefore, identification of new molecular effectors from metabolites of efficient microbes may be used as biopesticide and biofertilizer for commercial production of W. somnifera globally.

7.
J Gerontol A Biol Sci Med Sci ; 71(9): 1160-8, 2016 09.
Artículo en Inglés | MEDLINE | ID: mdl-26433219

RESUMEN

The advancements in the field of gerontology have unraveled the signaling pathways that regulate life span, suggesting that it might be feasible to modulate aging. To this end, we isolated a novel phytomolecule Acacetin 7-O-α-l-rhamnopyranosyl (1-2) ß-D-xylopyranoside (ARX) from Premna integrifolia and evaluated its antiaging effects in Caenorhabditis elegans The spectral data analysis revealed the occurrence of a new compound ARX. Out of the three tested pharmacological doses of ARX, viz. 5, 25, and 50 µM, the 25-µM dose was able to extend life span in C. elegans by more than 39%. The present study suggests that ARX affects bacterial metabolism, which in turn leads to dietary restriction (DR)-like effects in the worms. The effect of ARX on worms with mutations (mev-1, eat-2, sir-2.1, skn-1, daf-16, and hsf-1) indicates that ARX-mediated life-span extension involves mechanisms associated with DR and maintenance of cellular redox homeostasis. This study is the first time report on longevity-promoting activity of ARX in C. elegans mediated by stress and DR-regulating genes. This novel phytomolecule can contribute in designing therapeutics for managing aging and age-related diseases.


Asunto(s)
Envejecimiento , Caenorhabditis elegans/efectos de los fármacos , Flavonas/farmacología , Regulación de la Expresión Génica/efectos de los fármacos , Longevidad/efectos de los fármacos , Animales , Animales Modificados Genéticamente , Tamaño Corporal/efectos de los fármacos , Caenorhabditis elegans/genética , Caenorhabditis elegans/metabolismo , Proteínas de Caenorhabditis elegans/genética , Conducta Alimentaria/efectos de los fármacos , Flavonas/química , Estrés Oxidativo/efectos de los fármacos
8.
Int J Pharm Sci Res ; 7(7): 2830-2836, 2016. ilus, tab
Artículo en Inglés | MedCarib | ID: biblio-995723

RESUMEN

Paracetamol tablets are popular over the counter (OTC products among the patients as a good analgesics and antipyretics. The objective of this study was to compare the quality of the paracetamol tablet formulations those are locally available in Trinidad & Tobago pharmaceutical market manufactured by various pharmaceutical companies with pharmacopoeia standards. The four popular brands (A, B, C, D) of paracetamol conventional tablet of 500 mg strength were chosen. The paracetamol tablets were obtained from government hospital pharmacies as well as from local private pharmacies. To compare the quality of tablet formulations of different brands various official parameters like friability, weight variation, disintegration time, dissolution and drug assay tests were performed as per the pharmacopoeia. The result of all these parameters of different brands were in the pharmacopoeial limits so it could be concluded that marketed pharmaceutical tablets of paracetamol of these brands are safe, effective and efficacious as well as satisfy quality control limits of pharmacopoeia.


Asunto(s)
Humanos , Masculino , Femenino , Control de Calidad , Trinidad y Tobago , Preparaciones Farmacéuticas , Medicamentos sin Prescripción
9.
Free Radic Res ; 49(11): 1384-92, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-26189547

RESUMEN

The discovery of bioactive molecules modulating aging in living organism promotes development of natural therapeutics for curing age-related afflictions. The progression in age-related disorders can be attributed to increment in intracellular reactive oxygen species (ROS) and oxidative stress level. To this end, we isolated an iridoid verminoside (VMS) from Stereospermum suaveolens (Roxb.) DC. and evaluated its effect on Caenorhabditis elegans. The present study delineates VMS-mediated alteration of intracellular ROS, oxidative stress, and life span in C. elegans. The different tested doses of VMS (5 µM, 25 µM, and 50 µM) were able to enhance ROS scavenging and extend mean life span in C. elegans. The maximal life span extension was observed in 25 µM VMS, that is, 20.79% (P < 0.0001) followed by 9.84% (P < 0.0001) in 5 µM VMS and 8.54% (P < 0.0001) in 50 µM VMS. VMS was able to alleviate juglone-induced oxidative stress and enhanced thermotolerance in worms. The stress-modulating and ROS-scavenging potential of VMS was validated by increment in mean survival by 29.54% (P < 0.0001) in VMS-treated oxidative stress hypersensitive mev-1 mutant strain. Furthermore, VMS modulates expression of DAF-16 (a FoxO transcription factor) promoting stress resistance and longevity. Altogether, our results suggest that VMS attenuates intracellular ROS and stress (oxidative and thermal) level promoting longevity. The longevity and stress modulation can be attributed to VMS-mediated alterations in daf-16 expression which regulates insulin signaling pathway. This study opens doors for development of phytomolecule-based therapeutics for prolonging life span and managing age-related severe disorders.


Asunto(s)
Envejecimiento/fisiología , Proteínas de Caenorhabditis elegans/metabolismo , Caenorhabditis elegans/metabolismo , Iridoides/metabolismo , Animales , Longevidad , Estrés Oxidativo
10.
Artículo en Inglés | MEDLINE | ID: mdl-25619942

RESUMEN

Specioside (6-O-coumaroylcatalpol) is an iridoid glucoside which possesses multifunctional activities viz. analgesic, antidyspeptic, astringent, liver stimulating and wound healing properties. The present study for the first time delineates stress alleviating and lifespan prolonging action of specioside (SPC), isolated from Stereospermum suaveolens in the free living, multicellular nematode model Caenorhabditis elegans. A strong correlation between lifespan extension and stress modulation in adult worms was established in a dose dependent manner. The dietary intake of this phytomolecule elevated juglone induced oxidative and heat induced thermal stress tolerance in C. elegans. On evaluation, it was found that 25 µM dose of SPC significantly extended lifespan by 15.47% (P≤0.0001) with reduction in stress level. Furthermore, SPC enhanced mean survival in mev-1 mutant suggesting its oxidative stress reducing potential. Furthermore, SPC augmented stress modulatory enzymes superoxide dismutase (SOD) and catalase (CAT) level in C. elegans. Altogether, these findings broaden current perspectives concerning stress alleviating potentials of SPC and have implications in development of therapeutics for curing age related disorders.


Asunto(s)
Caenorhabditis elegans/efectos de los fármacos , Glucósidos Iridoides/farmacología , Animales , Longevidad , Estrés Oxidativo
11.
J Pharm (Cairo) ; 2014: 568320, 2014.
Artículo en Inglés | MEDLINE | ID: mdl-26556198

RESUMEN

The aim of this study was to prepare fast disintegrating combination tablet of taste masked Levocetrizine dihydrochloride and Montelukast sodium by using direct compression method. To prevent bitter taste and unacceptable odour of the Levocetrizine dihydrochloride drug, the drug was taste masked with ion exchange resins like Kyron-T-104 and Tulsion-412. Among the two resins, Kyron-T-104 was selected for further studies because of high drug loading capacity, low cost, and better drug release profile. An ion exchange resin complex was prepared by the batch technique and various parameters; namely, resin activation, drug: resin ratio, pH, temperature, and stirring time, and swelling time were optimized to successfully formulate the tasteless drug resin complex (DRC). The tablets were prepared using microcrystalline cellulose (MCC) PH 102 as diluent along with crospovidone (CP), croscarmellose sodium (CCM), and sodium starch glycolate (SSG) as a superdisintegrants. The tablets were evaluated for weight variation, hardness, friability, wetting time, water absorption ratio, disintegration time (DT), and dissolution study and it was concluded that the tablet formulation prepared with 2% SSG + CCS showed better disintegration time in comparison with other formulation and good drug release. The stability studies were carried out for the optimized batch for three months and it showed acceptable results.

12.
PLoS One ; 8(1): e52784, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-23382823

RESUMEN

Wounding is required to be made in the walls of the green seed pod of Opium poppy prior exudation of latex. To withstand this kind of trauma plants regulate expression of some metabolites through an induced transcript level. 167 unique wound-inducible ESTs were identified by a repetitive round of cDNA subtraction after 5 hours of wounding in Papaver somniferum seedlings. Further repetitive reverse northern analysis of these ESTs revealed 80 transcripts showing more than two fold induction, validated through semi-quantitative RT-PCR & real time expression analysis. One of the major classified categories among identified ESTs belonged to benzylisoquinoline transcripts. Tissue specific metabolite analysis of benzylisoquinoline alkaloids (BIAs) in response to wounding revealed increased accumulation of narcotine and papaverine. Promoter analysis of seven transcripts of BIAs pathway showed the presence of W-box cis-element with the consensus sequence of TGAC, which is the proposed binding site for WRKY type transcription factors. One of the Wound inducible 'WRKY' EST isolated from our subtracted library was made full-length and named as 'PsWRKY'. Bacterially expressed PsWRKY interacted with the W-box element having consensus sequence TTGACT/C present in the promoter region of BIAs biosynthetic pathway genes. PsWRKY further activated the TYDC promoter in yeast and transiently in tobacco BY2 cells. Preferential expression of PsWRKY in straw and capsule and its interaction with consensus W-box element present in BIAs pathway gene transcripts suggest its possible involvement in the wound induced regulation of BIAs pathway.


Asunto(s)
Bencilisoquinolinas/metabolismo , Etiquetas de Secuencia Expresada/metabolismo , Papaver/metabolismo , Factores de Transcripción/metabolismo , Alcaloides/química , Alcaloides/metabolismo , Regulación de la Expresión Génica de las Plantas , Redes y Vías Metabólicas , Papaver/genética , Proteínas de Plantas/genética , Proteínas de Plantas/metabolismo , Regiones Promotoras Genéticas , Homología de Secuencia de Aminoácido , Factores de Transcripción/genética , Heridas y Lesiones
13.
CNS Neurol Disord Drug Targets ; 11(8): 984-92, 2012 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-23244417

RESUMEN

Aging, the major cause of several ailments has led to intense exploration of potential drugs that delay aging and its associated effects. We mined the information on traditional Indian medicines and identified an iridoid, 10-O-trans-p-Coumaroylcatalpol (OCC), a major ingredient of Premna integrifolia Linn. (syn: Premna serratifolia). OCC forms an important constituent of famous herbal formulation 'Dashmula', a ten herb formulation, commonly used for its various medicinal properties. Employing model system C. elegans, the effect of OCC on life span, stress resistance, chemotaxis, the content of reactive oxygen species (ROS) and on the aggregation of alpha synuclein was studied. OCC extended the mean life span of nematodes, increased their tolerance against chemical induced stress, improved the chemotaxis index and reduced the ROS content. Further, the aggregation of Parkinson's disease (PD) associated protein, alpha synuclein (asyn), was decreased when transgenic a-syn expressing worms were raised on OCC mixed diet. We extended the studies further to explore the possible genetic mechanism that mediates the observed effects of OCC. Employing the genetic knockout mutants TK22 [mev-1(kn1)III]; GR1307 [daf-16(mgDf50)I]; VC199 [sir-2.1(ok434)IV] and transgenic GFP expressing strain TJ356 [zls356; DAF-16::GFP], our studies revealed that the effects were mediated by daf-16 and not by sir-2.1 or mev-1. Our results indicate that OCC has the ability to ameliorate a-syn aggregation, reduce oxidative stress and promote longevity in C. elegans via activation of longevity promoting transcription factor DAF-16. Thus, OCC may serve as a lead compound of plant origin for important nutraceutical intervention against aging and age associated PD.


Asunto(s)
Caenorhabditis elegans/efectos de los fármacos , Glucósidos Iridoides/farmacología , Longevidad/efectos de los fármacos , Extractos Vegetales/farmacología , alfa-Sinucleína/antagonistas & inhibidores , alfa-Sinucleína/metabolismo , Animales , Animales Modificados Genéticamente , Caenorhabditis elegans/genética , Caenorhabditis elegans/metabolismo , Glucósidos Iridoides/química , Glucósidos Iridoides/aislamiento & purificación , Longevidad/fisiología , Corteza de la Planta , Extractos Vegetales/química , Extractos Vegetales/aislamiento & purificación , Tallos de la Planta
14.
Free Radic Biol Med ; 53(10): 1848-56, 2012 Nov 15.
Artículo en Inglés | MEDLINE | ID: mdl-23000058

RESUMEN

In modern times, there has been a major increase in the use of plants or herbal constituents for the prevention of age-related disorders. 4-Hydroxy-E-globularinin (4-HEG) is an iridoid and a major component of Premna integrifolia. This investigation represents a breakthrough in geriatrics by showing the longevity-promoting activity of 4-HEG in the animal model Caenorhabditis elegans. 4-HEG (20µM) enhanced the mean life span of worms by over 18.8% under normal culture conditions and also enhanced their survival under oxidative stress. The longevity-promoting activity was associated with reduced reactive oxygen species (ROS) levels and fat accumulation in the worms. Gene-specific mutant studies verified the role of ROS detoxification pathways and simultaneous nuclear translocation of DAF-16 in the 4-HEG-mediated effects. Quantitative real-time PCR estimations and observations of transcriptional reporters indicated that 4-HEG was able to upregulate stress-inducible genes, viz., hsp-16.2 and sod-3. Thus, 4-HEG may serve as a lead compound of plant origin for the development of important nutraceuticals superseding the aging process.


Asunto(s)
Caenorhabditis elegans/efectos de los fármacos , Caenorhabditis elegans/fisiología , Iridoides/farmacología , Longevidad/efectos de los fármacos , Envejecimiento/efectos de los fármacos , Animales , Caenorhabditis elegans/genética , Caenorhabditis elegans/metabolismo , Proteínas de Caenorhabditis elegans/biosíntesis , Proteínas de Caenorhabditis elegans/genética , Proteínas de Caenorhabditis elegans/metabolismo , Quimiotaxis/efectos de los fármacos , Factores de Transcripción Forkhead , Radicales Libres/metabolismo , Regulación de la Expresión Génica/efectos de los fármacos , Genes de Helminto , Proteínas de Choque Térmico/biosíntesis , Proteínas de Choque Térmico/genética , Iridoides/química , Esperanza de Vida , Modelos Animales , Estrés Oxidativo/efectos de los fármacos , Corteza de la Planta/metabolismo , Especies Reactivas de Oxígeno/metabolismo , Transducción de Señal , Factores de Transcripción/metabolismo , Activación Transcripcional
15.
J Assoc Physicians India ; 56: 622-7, 2008 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-19051709

RESUMEN

Heparin induced thrombocytopenia (HIT) is a serious and life endangering complication of heparin therapy. It usually occurs after 5-14 days of continuous heparin therapy. It is immune mediated. Heparin, in the affected individual binds with platelet factor 4 (PF-4) and forms a highly antigenic Heparin PF-4 complex which leads to the generation of specific IgG Heparin PF4 antibodies (also called HIT antibodies). HIT antibodies may activate the platelets via Fcy receptor causing the release of highly coagulable micro particles which promote thrombosis--both venous and arterial. However, all patients with HIT antibodies do not progress to HIT with thrombosis (HITT). HIT can present as asymptomatic thrombocytopenia. It can also present with alarming features of venous and/or arterial thromboembolism, for example, pulmonary embolism from deep vein thrombosis (DVT), limb gangrene warranting amputation, cerebrovascular attack (CVA) or myocardial infarction (MI). Rare manifestation of HIT includes necrotizing skin lesion, acute anaphylactoid reaction following IV heparin bolus and acute adrenal apoplexy due to massive adrenal vein thrombosis. The diagnosis is based upon the combination of unexplained thrombocytopenia, demonstration of HIT antibodies, clinical profile and outcome of the case following withdrawal of heparin and administration of non-heparin anticoagulant like Lepirudin, Argatroban or Danaparoid. The choice of alternative anticoagulant depends upon the availability, cost, monitoring facilities and administrative guidelines.


Asunto(s)
Heparina/efectos adversos , Trombocitopenia/inducido químicamente , Anticoagulantes/efectos adversos , Anticoagulantes/uso terapéutico , Antitrombina III/uso terapéutico , Humanos , Incidencia , Trombina/antagonistas & inhibidores , Trombocitopenia/diagnóstico , Trombocitopenia/tratamiento farmacológico , Factores de Tiempo
16.
Med Res Rev ; 28(5): 746-72, 2008 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-17979145

RESUMEN

Medicinal plants have been traditionally used for treating liver diseases since centuries. Several leads from plant sources have been found as potential hepatoprotective agents with diverse chemical structures. Although, a big list of hepatoprotective phytomolecules was reported in the scientific literature, only a few were potent against various types of liver damages. Of which, silymarin, andrographolide, neoandrographolide, curcumin, picroside, kutkoside, phyllanthin, hypophyllanthin, and glycyrrhizin have largely attracted the scientific community. This review focuses discussion on the chemistry, biological activity, mode of action, toxicity, and future prospects of these leads.


Asunto(s)
Citocinas/metabolismo , Hepatopatías/tratamiento farmacológico , Hígado/efectos de los fármacos , Extractos Vegetales/farmacología , Sustancias Protectoras/farmacología , Animales , Cinamatos/química , Cinamatos/metabolismo , Cinamatos/farmacología , Cinamatos/toxicidad , Curcumina/química , Curcumina/metabolismo , Curcumina/farmacología , Curcumina/toxicidad , Diterpenos/química , Diterpenos/metabolismo , Diterpenos/farmacología , Diterpenos/toxicidad , Glucósidos/química , Glucósidos/metabolismo , Glucósidos/farmacología , Glucósidos/toxicidad , Ácido Glicirrínico/química , Ácido Glicirrínico/metabolismo , Ácido Glicirrínico/farmacología , Ácido Glicirrínico/toxicidad , Humanos , Lignanos/química , Lignanos/metabolismo , Lignanos/farmacología , Lignanos/toxicidad , Hígado/metabolismo , Hepatopatías/metabolismo , Fitoterapia , Extractos Vegetales/metabolismo , Extractos Vegetales/uso terapéutico , Extractos Vegetales/toxicidad , Plantas , Sustancias Protectoras/química , Sustancias Protectoras/metabolismo , Sustancias Protectoras/uso terapéutico , Sustancias Protectoras/toxicidad , Silimarina/química , Silimarina/metabolismo , Silimarina/farmacología , Silimarina/toxicidad , Tetrahidronaftalenos/química , Tetrahidronaftalenos/metabolismo , Tetrahidronaftalenos/farmacología , Tetrahidronaftalenos/toxicidad
17.
J Assoc Physicians India ; 56: 969-79, 2008 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-19322976

RESUMEN

Technology of drug-eluting stent (DES) implantation is relatively young. DES have remarkably reduced the incidence of stent-restenosis (SRS) and the need for target vessel revascularization (TVR). Yet it has added a small but significant risk of late and very late stent thrombosis (ST). The incidence of ST varies between 0.3-2.8% with a mean of 1.3%. ST occurs both with bare-metal stents (BMS) and drug-eluting stents (DES) but the time course differs with an excess of ST in the first six months of implantation with BMS while the number of ST is more with DES after 6 months of implantation. Despite this difference, there are no overall differences between BMS and DES regarding the end points of death or myocardial infarction (MI) on long term (3-5 years) follow-up. Endothelial dysfunction and incomplete neointimal coverage of stent strut remain the basic underlying mechanisms responsible for ST in DES. Stent thrombosis, though infrequent, is a dreadful condition. Over 30% may die suddenly. 60% develop massive MI with cardiogenic shock, poor LVEF and serious arrhythmias. The beneficial effects of primary percutaneous intervention (PCI) for ST are not spectacular, and TIMI flow grade III, is achieved in less than 80% cases, while distal embolization and residual dissection of coronary artery are frequently encountered. Proper selection and optimization of stent with prolonged dual antiplatelet therapy may prevent the undesirable stent thrombosis after DES implantation.


Asunto(s)
Prótesis Vascular/efectos adversos , Reestenosis Coronaria/complicaciones , Stents Liberadores de Fármacos/efectos adversos , Trombosis/etiología , Reestenosis Coronaria/tratamiento farmacológico , Humanos , Incidencia , Ensayos Clínicos Controlados Aleatorios como Asunto , Medición de Riesgo , Factores de Riesgo , Trombosis/epidemiología , Trombosis/patología , Trombosis/prevención & control , Trombosis/terapia , Factores de Tiempo , Resultado del Tratamiento
19.
Planta Med ; 73(14): 1486-90, 2007 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-18008199

RESUMEN

Although a number of chemicals have been isolated from Terminalia arjuna, only a few have been evaluated for their biological significance. As a part of our drug discovery programme for cytotoxic agents from Indian medicinal plants, four novel cytotoxic agents arjunic acid (1), arjungenin (2), arjunetin (3) and arjunoglucoside I (4) were isolated from the bark of T. ARJUNA. Out of the four compounds, arjunic acid (1) was significantly active against the human oral (KB), ovarian (PA 1) and liver (HepG-2 & WRL-68) cancer cell lines. Further, the most active compound arjunic acid was converted into seven semi-synthetic ester derivatives 5 - 11. 2-O-Palmitoyl arjunic acid (6) showed two times more activity, while 2, 3-di-O-acetyl-, 2-O-p-anisoyl-, 2, 3-di-O-benzoyl- and 2, 3-di-O-p-nitrobenzoyl arjunic acid (7 - 10) showed 1.7 - 2.3 times less activity than the cytotoxic drug vinblastine against the liver cancer cell lines HepG-2 and WRL-68 respectively.


Asunto(s)
Antineoplásicos Fitogénicos/química , Antineoplásicos Fitogénicos/farmacología , Terminalia/química , Línea Celular Tumoral , Humanos , Estructura Molecular
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA